Shifa International Hospitals Limited (PSX:SHFA)
Pakistan
· Delayed Price · Currency is PKR 451.22
+12.58 (2.87%)
At close: May 13, 2025
PSX:SHFA Revenue
Shifa International Hospitals had revenue of 6.95B PKR in the quarter ending March 31, 2025, with 20.46% growth. This brings the company's revenue in the last twelve months to 26.63B, up 16.84% year-over-year. In the fiscal year ending June 30, 2024, Shifa International Hospitals had annual revenue of 23.55B with 19.57% growth.
Revenue (ttm)
26.63B
Revenue Growth
+16.84%
P/S Ratio
1.07
Revenue / Employee
4.98M
Employees
5,348
Market Cap
28.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 23.55B | 3.85B | 19.57% |
| Jun 30, 2023 | 19.70B | 3.51B | 21.66% |
| Jun 30, 2022 | 16.19B | 1.97B | 13.84% |
| Jun 30, 2021 | 14.22B | 1.96B | 16.02% |
| Jun 30, 2020 | 12.26B | 486.22M | 4.13% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 61.15B |
| Abbott Laboratories (Pakistan) | 69.49B |
| AGP Limited | 26.27B |
| Highnoon Laboratories | 25.51B |
| The Searle Company | 28.80B |
| Citi Pharma | 13.19B |
| Ferozsons Laboratories | 18.16B |
| Otsuka Pakistan | 3.69B |